Navigation Links
Video: The Arizona Heart Institute Announces the Largest Worldwide Experience with Endoluminal Grafting to Treat Thoracic Aortic Aneurysms and Related Pathologies
Date:9/28/2007

/p>

correction) to type IV (graft porosity, rarely seen with current

devices). In the study, the occurrence of early endoleaks was low and

included 18 (5.5%) type I, four (1.2%) type II, and two (0.6%) type III

endoleaks.

-- Paraplegia: Thoracic ELG repair can cause decreased blood supply to the

spinal cord, leading to paraplegia. In this study, paraplegia occurred

in five (1.5%) patients and paresis (slight or partial paralysis) in

three (0.9%); two of the latter improved and one resolved completely

prior to discharge. Paraplegia remains low as a complication and

expectedly increases with difficult anatomy, specific conditions or

open surgical approach. Associated paraplegia with open repair is

estimated at 4%.

-- Mortality: At short-term follow-up, 18 (5.5%) deaths related to the

underlying thoracic aortic pathology occurred within the first thirty

days of the procedure, including three intraoperative deaths. Late

mortality was 9.6% with 31 deaths unrelated to the procedure or

underlying condition.

-- Complications: The overall complication rate was 22.7%, 14.2% (46) in

elective cases and 8.5% (28) in non-elective cases. The vast majority

of these were minor and easily managed with satisfactory outcomes.

Thoracic Aortic Aneurysms and Related Conditions

The aorta is the largest artery in the human body which carries blood away from the heart, with the thoracic aorta being the portion of the aorta coursing through the chest. When a weak area of the thoracic aorta expands or bulges like a balloon, it is called a thoracic aortic aneurysm (TAA). TAAs are often caused by atherosclerosis, or hardening and weakening of the arteries. An aortic dissection, which is often associated with high blood pressure, occurs when blood flow forces apart and weakens the aortic wall layers, often leading to ane
'/>"/>

SOURCE The Arizona Heart Institute
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
2. Lexicon Develops Antibodies That Lower Triglycerides and Cholesterol as Potential New Therapy for Heart Disease
3. Research Documents Scalable Production, Survival Following Engraftment and Positive Impact on Cardiac Function in Infarcted Rats for Gerons Human Embryonic Stem Cell-Based Therapeutic for Heart Failure
4. Treating Heart Disease Risk Factors May Slow Alzheimers Disease Progression
5. Pilot Phase 3 Results of NovaCardias KW-3902 for Acute Congestive Heart Failure Presented at Late-Breaking Session of Heart Failure Congress 2007
6. Drug for Treatment of Heart Failure Does Not Improve Survival, Compared to More Widely-used Medication
7. deCODE Announces Positive Topline Results for Phase I Study of DG051 for the Prevention of Heart Attack
8. Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events in Landmark Jikei Heart Study
9. Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events in Landmark Jikei Heart Study
10. First Controlled Large-Scale Intervention Angiotensin Receptor Blocker (ARB) Trial in a Japanese Population, JIKEI HEART Study Demonstrates Significant Reduction in Blood Pressure and Protection of Organs with Valsartan
11. New Anti-Rejection Medication 6-Month Results for Heart Transplant Recipients to Be Released at International Heart and Lung Transplant Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... , Dec. 18, 2014  Decision Resources Group ... the United States will increase to a ... be primarily driven by expansion in the large direct ... devices will be increasingly adopted due to the advantages ... Other key findings from Decision Resources Group,s coverage ...
(Date:12/19/2014)... , Dec. 18, 2014 Since last ... the site now known as the leading online black ... seen explosive growth in its offering of drugs and ... Alliance show the takedowns did succeed in lowering the ... last review of the markets in August. But some ...
(Date:12/17/2014)... SAN DIEGO , Dec. 17, 2014 ... PHIA) and Volcano Corporation (NASDAQ: VOLC ), a ... applications, today announced that they have entered into a definitive ... tender offer to acquire all of the issued and outstanding ... total equity purchase price of USD 1 billion (approx. EUR ...
Breaking Medicine Technology:U.S. Laparoscopic Device Market Will Reach Over $4.3 Billion by 2023 2U.S. Laparoscopic Device Market Will Reach Over $4.3 Billion by 2023 3Post Silk Road - Another Online Drug Den Now Dominates the DarkNet 2Post Silk Road - Another Online Drug Den Now Dominates the DarkNet 3Philips to acquire Volcano to expand global leadership position in image-guided therapy market 2Philips to acquire Volcano to expand global leadership position in image-guided therapy market 3Philips to acquire Volcano to expand global leadership position in image-guided therapy market 4Philips to acquire Volcano to expand global leadership position in image-guided therapy market 5Philips to acquire Volcano to expand global leadership position in image-guided therapy market 6Philips to acquire Volcano to expand global leadership position in image-guided therapy market 7Philips to acquire Volcano to expand global leadership position in image-guided therapy market 8
... July 5, 2011 Allure Medical Spa released an ... and to help them visualize potential outcomes. "Many of ... the newest treatments," explains board certified cosmetic surgeon, Dr. ... digital resource in the palm of their hands that ...
... 5, 2011 Dr. Michael Lowenstein, co-medical director of ... detoxification under deep sedation, is expressing grave concern over ... alarming rise in number of individuals seeking treatment for ... The new national analysis from the U.S. ...
Cached Medicine Technology:Cosmetic Surgery iPhone App Teaches and Amuses 2Waismann Method Medical Director Cautions of Increasing Numbers of Opioid Addicts 2
(Date:12/19/2014)... (PRWEB) December 20, 2014 The Medspa ... new injectable filler from respected cosmetic brand Juvéderm. Voluma ... naturally with age. The Medspa at Hendrick is pleased ... in skin care technology to its clients. , Voluma ... to be FDA-approved to treat the mid-face and cheek ...
(Date:12/19/2014)... Dec. 19, 2014 (HealthDay News) -- New research warns parents that ... lives at risk. Nearly half of teen drivers killed in ... were at least 11 years old and often lacked important safety ... Eighty-two percent of teen drivers killed in crashes were in cars ... to 10 years old, 31 percent were in cars 11 to ...
(Date:12/19/2014)... All children should have their eyesight checked between the ... experts say. The new vision-screening guidelines for preschool-aged ... National Center for Children,s Vision Health. The panel ... for eye problems, particularly vision issues that require ... strabismus (a disorder of eye alignment). Early detection ...
(Date:12/19/2014)... 19, 2014 (HealthDay News) -- Injectable drug users who ... suicide attempt rate of other substance users, a new ... associated with the risk of suicide attempt and completed ... of Montreal, said in a university news release. "However, ... wanted to know who among substance users were actually ...
(Date:12/19/2014)... 2014 (HealthDay News) -- The cost of cancer treatment ... new study finds. Researchers examined data from 1,000 ... with colorectal or lung cancer. Of those patients, almost ... more than 100 had advanced cancer. Nearly half ... their medical bills, which was linked with a poorer ...
Breaking Medicine News(10 mins):Health News:Breakthrough New Injectable Dermal Filler Voluma XC Offered by The MedSpa at Hendrick 2Health News:Older Cars a Bad Choice for Younger Drivers 2Health News:Preschoolers Need Eye Screening, Experts Say 2Health News:Cocaine, Amphetamines May Up Injection Drug Users' Suicide Risk 2Health News:Cancer Treatment Costs Weigh Heavily on Patients, Study Finds 2
... to Follow Dispute Resolution Process is ... the Most Expeditious Path to Final Approval -, ... DDS;,NASDAQ: DDSS) today announced that it has appealed the ... tramadol formulation to,the next supervisory level under the FDA,s ...
... -- Simcere,Pharmaceutical Group (NYSE: SCR ), a ... manufacturer of the patented,anti-cancer biotech product Endu in ... & Co.,s Fourth Investor Tour of China,being held ... 4, 2008 in Beijing,Shenzhen and Shanghai., Simcere,s ...
... New Consumer Label, WICHITA, Kan., April 1, ... that include new best practices,animal husbandry, biosecurity, and ... by VeriPrime, Inc., of Wichita, KS, at the,recommendation ... (Logo: http://www.newscom.com/cgi-bin/prnh/20080401/AQTU070LOGO ), The Advisory Council ...
... Fork, Care and Prevention, WICHITA, Kan., April ... and higher new safety standards, including protections,against E. ... leading farmers and,ranchers behind the food safety seal, ... Citing growing consumer concern over food safety ...
... and OTTAWA, April 1, 2008 Natural,Nutrition, Inc. ... that its operating,subsidiary, InterACTIVE Nutrition, Inc. (INII) achieved ... million (CDN) in EBITDA for the,year ended December ... Nutrition, stated, "We are pleased to,report record results ...
... China,Shenghuo Pharmaceutical Holdings, Inc. (Amex: KUN ) ... the research, development, manufacture,and marketing of pharmaceutical, nutritional ... China ("PRC"), announced its financial,results for full year ... 2007 Highlights -- Net sales totaled ...
Cached Medicine News:Health News:Labopharm Appeals FDA's Decision on Once-Daily Tramadol to Next Supervisory Level After Additional Analysis Supports Efficacy 2Health News:Labopharm Appeals FDA's Decision on Once-Daily Tramadol to Next Supervisory Level After Additional Analysis Supports Efficacy 3Health News:Simcere Pharmaceutical Group Announces Participation in Brean Murray Carret & Co.'s Fourth Investor Tour of China 2Health News:VeriPrime Approves New Best Practices for Beef Production 2Health News:VeriPrime Approves New Best Practices for Beef Production 3Health News:'VeriPrime Certified Safeguards' Food Safety Label Unveiled 2Health News:'VeriPrime Certified Safeguards' Food Safety Label Unveiled 3Health News:Natural Nutrition Subsidiary Reports Record Year-End Revenue and EBITDA 2Health News:China Shenghuo Reports Full Year 2007 Financial Results 2Health News:China Shenghuo Reports Full Year 2007 Financial Results 3Health News:China Shenghuo Reports Full Year 2007 Financial Results 4Health News:China Shenghuo Reports Full Year 2007 Financial Results 5Health News:China Shenghuo Reports Full Year 2007 Financial Results 6Health News:China Shenghuo Reports Full Year 2007 Financial Results 7Health News:China Shenghuo Reports Full Year 2007 Financial Results 8Health News:China Shenghuo Reports Full Year 2007 Financial Results 9Health News:China Shenghuo Reports Full Year 2007 Financial Results 10Health News:China Shenghuo Reports Full Year 2007 Financial Results 11Health News:China Shenghuo Reports Full Year 2007 Financial Results 12Health News:China Shenghuo Reports Full Year 2007 Financial Results 13
Mini-Finesse 5mm Dilating Trocar, hook electrode, two lengths, mini or basic kit....
Thoracoscopy Cannula, reusable, hook electrode, two lengths, mini or basic kit....
... Sleeve consists of a rounded ... to prevent puncture or laceration ... cavity has been entered. The ... the sleeve which enhance security ...
... three separate components: an exchange rod, a dilating ... trocar sleeve. The exchange rod is a rigid ... The dilating obturator is tapered and threaded at ... created by the 10/11mm or the 12mm ENDOPATH ...
Medicine Products: